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Abstract 
Enterococci are important pathogens caus-
ing nosocomial infections and patients at risk
include also premature babies requiring inten-
sive  care  treatment.  Our  aim  was  to  assess
occurrence  and  cross  transmission  rates  of
enterococci among neonatal patients of a hos-
pital ward during a two months period. Rectal
and skin samples were taken between day one
and 60 of infants’ age. Colonization with vari-
ous potentially pathogenic bacteria was corre-
lated with developing a subsequent infection.
Enterococcal isolates were identified by colony
morphology.  The  bacterial  species  was
assessed and antibiotic susceptibilities were
determined. A molecular analysis of 20 investi-
gated  enterococcal  isolates  revealed  preva-
lence  of  commensal  strain  types;  hospital-
associated strain types or multi-resistant vari-
ants were absent. Cross transmission of E. fae-
cium and E. faecalis isolates among neonatal
patients attending the intensive crare unit at
the same time was demonstrable. Introduction
of hospital-associated, multi-resistant variants
into this special setting has to be avoided to
reduce the risk of subsequent infections.
Introduction
Rates  of  enterococcal  infections  among
patients in intensive care increased dramati-
cally  in  the  last  two  decades  worldwide.1
Enterococcal  isolates  (Enterococcus  faecalis
and E. faecium) are ranked as the second most
important  nosocomial  pathogen  in  intensive
crare unit (ICU) acquired bloodstream infec-
tions in Europe.2 Infections occur in severely
ill and immuno-compromised patients reveal-
ing  also  premature  babies  and  newborns  at
risk  for  acquiring  enterococcal  infections.3,4
Transmission rates of enterococcal isolates are
high among nosocomial patients, even higher
than  for  S.  aureus  and  E.  coli.5  Increased
importance of enterococci especially E. faeci-
um as a nosocomial pathogen is linked to a
preferred  prevalence  of  hospital-associated
strain types that possess acquired antibiotic
resistance properties, specific molecular mark-
ers and clonal types identifiable by molecular
typing  techniques  such  as  Multi-locus
sequence typing (MLST).6 On the other hand,
commensal clonal types of E. faecalis and E.
faecium exhibit important constituents of the
healthy human intestinal flora and are among
the first and early colonizers of the infants’
intestines.7 In the present study we investigat-
ed rectal (and skin) colonization, cross-trans-
mission rates and clonal types of enterococci
among  newborns  of  a  neonatal  ICU  of  a
German hospital over a period of two months.      
Brief Report
From April to May 2006, 20 patients attend-
ing a German neonatal ICU were screened for
bacterial rectal and skin colonizations. All new-
borns were admitted to a separate ward and
were kept aside from other pediatric patients.
Samples  were  taken  in  relation  to  clinical
signs of infection of the babies (fever, etc.) or
when mothers had risk factors or infections
(amnion infection, vaginal group B streptococ-
cus colonization, etc). Potentially pathogenic
bacteria such as Staphylococcus aureus, coagu-
lase-negative  staphylococci,  Enterobacteria  -
ceae and Enterococcus spp. were assessed. Five
patients were rectally screened consecutively,
two  and  three  times,  respectively  (Table  1).
Rectal  and  skin  samples  were  primarily
screened  on  two  non-selective  media;
Brilliance  UTI  Clarity  agar  (Oxoid/Thermo
Fischer  Scientific,  Wesel,  Germany)  and
Trypticase  Soy-Agar  +  5%  Sheep  Blood
(bioMerieux,  Nuertingen,  Germany).
Morphologically different isolates per sample
were  further  identified  by  Vitek® 2
(bioMerieux, Nürtingen, D). All but three ente-
rococcal isolates were available for a subse-
quent analysis. Antibiotic susceptibilities for
enterococci  were  initially  determined  by
VITEK® 2 (bioMérieux, according to CLSI cri-
teria and later confirmed by an in house micro-
broth dilution method.8 Epidemiological mark-
ers to differentiate hospital-associated strains
of  E.  faecium from  colonizing  variants  were
determined by PCR as described recently (esp,
hylEfm, IS16)..9,10 To investigate clonal related-
ness  of  strains  macrorestriction  analysis  in
Pulsed-Field  Gel  Electrophoresis  was  per-
formed as described9 and subsequent analysis
was done using a Dice coefficient and UPGMA
clustering (BioNumercis v. 5.1; Applied Maths,
Belgium).  Multi-locus  sequence  typing
(MLST)  was  performed  to  differentiate
between  commensal  and  hospital-associated
strain types as given elsewhere (http://efaeci-
um.mlst.net/ and http://efaecalis.mlst.net/). 
Results
Of the 20 screened neonatal patients only
two samples did not grow bacteria at all (of the
genera and species described above; Table 1).
Ten  neonatal  patients  showed  signs  of  an
infection  and  received  immediate  antibiotic
treatment (Table 1). Screening samples of 18
patients grew enterococci and from 14 children
isolates  were  accessible.  From  two  patients
consecutive isolates were analyzed (Figure 1).
Altogether eight E. faecalis and eight E. faeci-
um isolates  were  available  for  a  molecular
analysis.  Antibiotic  susceptibility  testing
revealed  a  very  small  spectrum  of  acquired
resistances; mainly erythromycin (E. faecium)
and tetracycline (E. faecalis; Figure 1) repre-
senting widespread acquired resistance char-
acteristics also prevalent among animal, envi-
ronmental and human colonizing, commensal
enterococcal  strains.  Molecular  markers  of
hospital-associated  E.  faecium  strains  (esp,
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hylEfm, IS16) were absent in the eight E. faeci-
um isolates.  MLST  results  confirmed  preva-
lence  of  commensal  E.  faecium strain  types
among  the  investigated  patients  (Figure  1).
Four  isolates  of  E.  faecalis revealed  MLST
strain type ST40 known to be highly prevalent
among various ecological sources and which is
also isolated from severe invasive infections
like endocarditis and sepsis11 and from cases
of  bovine  mastitis  (Zischka  and  Werner,
unpublished data). However, hospital-associat-
ed strain types belonging to clonal complexes
CC2 and CC9 were not identified among the E.
faecalis isolates. Cross transmission between
the  newborn  babies  attending  the  neonatal
ICU at the same time period was demonstrated
for E. faeciumand E. faecalisisolates as well as
ongoing  colonization  with  identical  strain
types in single neonates (Figure 1).
Conclusions
A microbiological and molecular analysis of
the enterococcal isolates from stool coloniza-
tions  in  newborn  infants  of  a  neonatal  ICU
revealed prevalence of colonizing strain types.
Hospital-associated  strain  types  or  multi-
resistant  variants  were  not  identified.
Nevertheless,  also  colonizing  strain  types
could  cause  endogenous  enterococcal  infec-
tions;  however,  the  pathogens  causing  the
described invasive infections could not been
identified here. Cross transmission of entero-
coccal isolates among newborns attending the
neonatal ICU at the same time was shown. To
elucidate the source of these early colonizing
isolates, an independent and comprehensive
follow-up study including stool sampling and
subsequent analyses from babies’ mothers and
medical staff is planned.  
References
1. Arias CA, Murray BE. Antibiotic-resistant
bugs in the 21st century--a clinical super-
challenge. N Engl J Med 2009;360:439-43.
2. Fifteen  most  frequently  isolated  micro-
organisms  in  ICU-acquired  bloodstream
infections  by  country,  results  from  the
HAI-HELICS projects, 2008. In: Annual epi-
demiological report on communicable dis-
eases in Europe in 2008. Available from:
www.ecdc.europa.eu
3. Haas EJ, Zaoutis TE, Prasad P, et al. Risk
factors  and  outcomes  for  vancomycin-
resistant Enterococcus bloodstream infec-
tion  in  children.  Infect  Control  Hosp
Epidemiol 2010;31:1038-42.
4. Faust K, Goepel W, Herting E, Haertel C.
[Sepsis in very low weight birth infants.]
Chemother  J  2010;20:1-8.  [Article  in
German]
5. Barwolff S, Grundmann H, Schwab F, et al.
[Incidence of transmission of pathogens
in intensive care units. Results of the SIR
3  study].  Anaesthesist  2005;54:560-6.
[Article in German]
6. Leavis  HL,  Bonten  MJ,  Willems  RJ.
Identification  of  high-risk  enterococcal
clonal  complexes:  global  dispersion  and
antibiotic resistance. Curr Opin Microbiol
2006;9:454-60.
7. Fanaro S, Chierici R, Guerrini P, Vigi V.
Intestinal microflora in early infancy: com-
position  and  development.  Acta  Paeditr
Suppl 2003;441:48-55.
8. CLSI.  Performance  Standards  for
Antimicrobial Susceptibility Testing, 16th
Informational  Supplement,  M100-S16,
2006;26(3):52-55.  Available  from:
www.microbiolab -bg.com/CLSI.pdf
9. Werner G, Fleige C, Ewert B, et al. High-
level ciprofloxacin resistance among hos-
pital-adapted  Enterococcus  faecium
(CC17). Int J Antimicrob Agents 2010;35:
119-25.
10. Werner G, Fleige C, Geringer U, et al. IS
element IS16 as a molecular screening tool
to identify hospital-adapted strains of E.
faecium. BMC Inf Dis 2011;11:80. 
11. McBride SM, Fischetti VA, Leblanc DJ, et
al. Genetic diversity among Enterococcus
faecalis. PLoS One 2007;2:e582.
Brief Report
Figure 1. SmaI macrorestriction patterns in Pulsed-Field Gel Electrophoresis (PFGE) of
all enterococcal isolates colonizing neonatal patients. Clusters of related isolates from
samples of different neonates suggest horizontal transmission between patients (clonal
spread), for instance, isolates E. faecalis UW6724 [Patient no. 3], UW6731 [Patient no.
4], and UW6726 [Patient no. 6]. MLST types in parentheses are predicted according to
an identical PFGE profile. Profiles ST-NEW1 and ST-NEW2 are new MLST types due to
new (N) allele sequences which have the following allelic profiles: ST-NEW1 [N-8-8-N-
6-27-6];  ST-NEW2  [25-8-N-17-10-N-6]  (see  also  http://efaecium.mlst.net/  and
http://efaecalis.mlst.net/).  ERY(i),  erythromycin  (intermediate);  TET,  tetracycline;
MLST, Multi-locus sequence typing; ST, sequence type (of MLST); n.d., not determined. 